These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8437630)

  • 21. Immunotherapy of sepsis syndrome: a comparison of the available treatments.
    Fisher CJ; Bellingan G
    Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Schentag JJ
    JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766
    [No Abstract]   [Full Text] [Related]  

  • 23. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy, safety, and therapeutic usage of HA-1A and E5 in the treatment of gram-negative sepsis.
    Quintiliani R; Cooper B; Maderazo E; Nightingale C
    Hosp Formul; 1992 Jan; 27(1):49-52, 54, 57-60. PubMed ID: 10116116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections.
    Fink MP
    Crit Care Med; 1995 Jun; 23(6):989-91. PubMed ID: 7774236
    [No Abstract]   [Full Text] [Related]  

  • 27. Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.
    Pollack M; Ohl CA
    Curr Top Microbiol Immunol; 1996; 216():275-97. PubMed ID: 8791745
    [No Abstract]   [Full Text] [Related]  

  • 28. Human monoclonal antibody against endotoxin.
    Zarowitz BJ
    DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monoclonal anti-endotoxin antibodies in the treatment of patients with sepsis due to Gram-negative bacteria].
    Speelman P; van Deventer SJ
    Ned Tijdschr Geneeskd; 1991 May; 135(20):877-8. PubMed ID: 2046787
    [No Abstract]   [Full Text] [Related]  

  • 30. [Monoclonal antibodies in the treatment of septic shock].
    Trilla A; Alonso P
    Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
    [No Abstract]   [Full Text] [Related]  

  • 31. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endotoxin adsortion as adjuvant therapy in gram negative severe sepsis].
    Candel FJ; Martínez-Sagasti F; Borges M; Maseda E; Herrera-Gutiérrez M; Garnacho-Montero J; Maynar FJ; Zaragoza R; Mensa J; Azanza JR
    Rev Esp Quimioter; 2010 Sep; 23(3):115-21. PubMed ID: 20844841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Spalter J
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiendotoxin therapy in sepsis.
    Colletti RC; Dew RB; Goulart AE
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):345-54. PubMed ID: 8398040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylaxis and treatment of newborn endotoxic shock with anti-lipid A monoclonal antibodies.
    Goto M; Zeller WP; Hurley RM; Jong JS; Lee CH
    Circ Shock; 1991 Sep; 35(1):60-4. PubMed ID: 1742861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo].
    Wortel CH; von der Möhlen MA; van Deventer SJ; Schipper HG; Lorijn RH; ten Cate JW
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):350-4. PubMed ID: 8437633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers.
    Talan DA
    Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
    JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1991 Oct; 39(3-4):129-30. PubMed ID: 1791872
    [No Abstract]   [Full Text] [Related]  

  • 40. Centoxin.
    Davidson J; Tarlow M
    Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):121-2. PubMed ID: 8435673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.